Clinical Trial Update: GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating GT101 injection for metastatic or recurrent solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• GT101

Snippet

Sponsor: Grit Biotechnology | Conditions: Solid Tumors, Adult | Phase 1 | Status: RECRUITING